Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - NOVAVAX INCv319119_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - NOVAVAX INCv319119_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - NOVAVAX INCv319119_ex32-1.htm
EXCEL - IDEA: XBRL DOCUMENT - NOVAVAX INCFinancial_Report.xls
10-Q - FORM 10-Q - NOVAVAX INCv319119_10q.htm

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT
TO 18 UNITED STATES C. §1350
(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

 

In connection with the Quarterly Report of Novavax, Inc. (the “Company”) on Form 10-Q for the fiscal period ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frederick W. Driscoll, Vice President, Chief Financial Officer and Treasurer, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

 

1)                   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2)                   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the dates and periods covered by this Report.

 

   
Date: August 9, 2012 By:  /s/ Frederick W. Driscoll
    Vice President, Chief Financial Officer and Treasurer